VBI VACCINES INC/BC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Published: 2022-01-26 08:02:07 ET VBIV

Item 7.01 Regulation FD Disclosure.

On January 26, 2022, VBI Vaccines Inc. (the "Company") issued a press release reporting that it will participate in the B. Riley Securities 2022 Oncology Investor Conference. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. The Company undertakes no obligation to update, supplement or amend the materials attached hereto.

The information in this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is being furnished pursuant to Item 7.01 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise be subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.